The research roundup provides an overview of the past week’s research from Mayo Clinic Laboratories consultants, including featured abstracts and a complete list of published studies and reviews.
The burden of esophageal cancer (EC) continues to rise, and non-invasive screening tools are needed. Methylated DNA markers (MDMs) assayed from plasma show promise in detection of other cancers. For EC detection, we aimed to discover and validate MDMs in tissue, and determine their feasibility when assayed from plasma. Via Clinical Cancer Research.